Turan N N, Demiryürek A T, Celebi H
Department of Pharmacology, Faculty of Pharmacy, Gazi University, Ankara, Turkey.
Pharmacol Res. 2000 Nov;42(5):453-8. doi: 10.1006/phrs.2000.0729.
Lidocaine has been demonstrated to modify both contraction and relaxation of the vascular smooth muscle. Although lidocaine has been shown to inhibit endothelium-independent relaxations, the effects of lidocaine on arterial relaxation induced by peroxynitrite, a reaction product of superoxide and nitric oxide, have not been studied. The current study was designed to evaluate the effects of lidocaine on endothelium-dependent and -independent relaxations in isolated rabbit thoracic aorta. Rings of the rabbit thoracic aorta with or without endothelium were mounted for isometric force recording. Concentration-response curves to calcium ionophore A23187 ( 10(-9)to 3 x 10(-6)m), acetylcholine ( 10(-9)to 10(-3)m), sodium nitroprusside (SNP, 10(-9)to 10(-3)m), and peroxynitrite ( 10(-9)to 10(-3)m) were obtained in a cumulative manner. Lidocaine ( 10(-6)to 10(-4)m) was applied 15 min before addition of phenylephrine. Under resting force, lidocaine produced contractions at high concentrations ( 10(-5)to 10(-2)m) in endothelium-intact and -denuded arteries but removal of the endothelium did not significantly affect contractile activity. In phenylephrine-precontracted arteries, lidocaine caused concentration-dependent relaxations in both endothelium-intact and -denuded arteries. Inhibition of nitric oxide synthase or removal of endothelium did not affect the relaxations to lidocaine. Lidocaine suppressed the endothelium-independent relaxations of peroxynitrite, also poly (ADP-ribose) synthetase (PARS) enzyme activator, and SNP at high concentrations. Concentration-dependent vascular relaxations to A23187 and acetylcholine were significantly inhibited by lidocaine. These results suggest that lidocaine can depress vascular relaxations by a complex mechanism including inhibition of PARS enzyme activity.
利多卡因已被证明可改变血管平滑肌的收缩和舒张。尽管利多卡因已被证明能抑制非内皮依赖性舒张,但尚未研究其对超氧化物和一氧化氮反应产物过氧亚硝酸盐诱导的动脉舒张的影响。本研究旨在评估利多卡因对离体兔胸主动脉内皮依赖性和非内皮依赖性舒张的影响。将有或无内皮的兔胸主动脉环安装用于等长力记录。以累积方式获得对钙离子载体A23187(10^(-9)至3×10^(-6)m)、乙酰胆碱(10^(-9)至10^(-3)m)、硝普钠(SNP,10^(-9)至10^(-3)m)和过氧亚硝酸盐(10^(-9)至10^(-3)m)的浓度-反应曲线。在加入去氧肾上腺素前15分钟应用利多卡因(10^(-6)至10^(-4)m)。在静息张力下,利多卡因在高浓度(10^(-5)至10^(-2)m)时在有内皮和无内皮的动脉中均可产生收缩,但去除内皮并未显著影响收缩活性。在去氧肾上腺素预收缩的动脉中,利多卡因在有内皮和无内皮的动脉中均可引起浓度依赖性舒张。抑制一氧化氮合酶或去除内皮并不影响对利多卡因的舒张反应。利多卡因在高浓度时可抑制过氧亚硝酸盐(也是聚(ADP-核糖)合成酶(PARS)酶激活剂)和SNP的非内皮依赖性舒张。利多卡因可显著抑制对A23187和乙酰胆碱的浓度依赖性血管舒张。这些结果表明,利多卡因可通过包括抑制PARS酶活性在内的复杂机制抑制血管舒张。